GILZ: Glitzing up our understanding of the glucocorticoid receptor in psychopathology

Brain Research

Volumn 1574, Issue , 2014, Pages 60-69

  Thiagarajah, Angeline S ^a   Eades, Laura E ^a   Thomas, Prabakar R ^b   Guymer, Emma K ^a   Morand, Eric F ^a   Clarke, David M ^a   Leech, Michelle ^a  

^a MONASH UNIVERSITY   (Australia)

^b Delmont Private Hospital   (Australia)

Author keywords

Depression; Fibromyalgia; GILZ; Glucocorticoid receptor; HPA axis; PTSD

Indexed keywords

GLUCOCORTICOID INDUCED LEUCINE ZIPPER; GLUCOCORTICOID RECEPTOR; LEUCINE ZIPPER PROTEIN; MINERALOCORTICOID RECEPTOR; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR;

DEPRESSION; DISEASE ASSOCIATION; FIBROMYALGIA; GENETIC TRANSCRIPTION; GLUCOCORTICOID RECEPTOR DYSFUNCTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL DISEASE; MENTAL STRESS; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; DEPRESSIVE DISORDER; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM;

ANIMALS; DEPRESSIVE DISORDER; FIBROMYALGIA; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; STRESS DISORDERS, POST-TRAUMATIC; TRANSCRIPTION FACTORS;

EID: 84925363853     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.06.008     Document Type: Review

References (87)

1. Adell, A., Celada, P., Abellán, M.T., Artigas, F., 2002. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Rev. 39, 154-180.
2. Alesci, S., Martinez, P.E., Kelkar, S., Ilias, I., Ronsaville, D.S., Listwak, S.J., Ayala, A.R., Licinio, J., Gold, H.K., Kling, M.A., Chrousos, G.P., Gold, P.W., 2005. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 90, 2522-2530.
3. Angst, 2007. Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatr. Scand. 115, 72-84.
4. Ashwell, J.D., Lu, F.W., Vacchio, M.S., 2000. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18, 309-345.
5. Asselin-Labat, M.L., Biola-Vidamment, A., Kerbrat, S., Lombes, M., Bertoglio, J., Pallardy, M., 2005. FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol. Endocrinol. 19, 1752-1764.
6. Ayroldi, E., 2001. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98, 743-753.
7. Ayroldi, E., Riccardi, C., 2009. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 23, 3649-3658.
8. Bandaru, S.S., Lin, K., Roming, S.L., Vellipuram, R., Harney, J.P., 2010. Effects of PI3K inhibition and low docosahexaenoic acid on cognition and behavior. Physiol. Behav 100, 239-244.
9. Beaulieu, E., Ngo, D., Santos, L., Yang, Y.H., Smith, M., Jorgensen, C., Escriou, V., Scherman, D., Courties, G., Apparailly, F., Morand, E. F., 2010. Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum. 62, 2651-2661.
10. Boyle, M.P., Brewer, J.A., Funatsu, M., Wozniak, D.F., Tsien, J.Z., Izumi, Y., Muglia, L.J., 2005. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Nat. Acad. Sci. U.S. A 102, 473-478.
11. Brady, 1992. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res 572, 117-125.
12. Broccoletti, T., Del Giudice, E., Cirillo, E., Vigliano, I., Giardino, G., Ginocchio, V., Bruscoli, S., Riccardi, C., Pignata, C., 2011. Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia. Eur. J. Neurol. 18, 564-570.
13. Brown, E.S., 2009. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann. N.Y. Acad. Sci. 1179, 41-55.
14. Burt, D.B., Zembar, M.J., Niederehe, G., 1995. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol. Bull 117, 285-305.
15. Cannarile, L., Cuzzocrea, S., Santucci, L., Agostini, M., Mazzon, E., Esposito, E., Muia, C., Coppo, M., Di Paola, R., Riccardi, C., 2009. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 136, 530-541.
16. Carroll, B.J., Iranmanesh, A., Keenan, D.M., Cassidy, F., Wilson, W.H., Veldhuis, J.D., 2012. Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. Acta Psychiatr. Scand. 125, 478-491.
17. Cassano, P., Fava, M., 2002. Depression and public health: an overview. J. Psychosom. Res. 53, 849-857.
18. Clark, A., 2007. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell. Endocrinol. 275, 79-97.
19. D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., Riccardi, C., 1997. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7, 803-812.
20. DeBattista, 2006. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol. Psychiatry 60, 1343-1349.
21. Fagan, E.M., Dempsey, C., Tallon, E., Connor, T.J., 2013. 81. IFN-alpha and IL-6 reduce glucocorticoid sensitivity in murine microglia: a role for FKBP5?. Brain Behav. Immun 32 (Suppl.), e23-e24.
22. Fan, H., Morand, E.F., 2012. The role of GILZ in anti-inflammatory and immunosuppressive actions of glucocorticoids, Glucocorticoids-New recognition of Our Familiar Friend. InTech (Vol., X. Qian, (Ed.).
23. Filioini, D., Gijsbers, K., Birmingham, M.K., Dubrovsky, B., 1991. Effects of adrenal steroids and their reduced metabolites on hippocampal long-term potentiation. J. Steroid Biochem. Mol. Biol. 40, 87-92.
24. Fiol, D.F., Mak, S.K., Kultz, D., 2007. Specific TSC22 domain transcripts are hypertonically induced and alternatively spliced to protect mouse kidney cells during osmotic stress. FEBS J. 274, 109-124.
25. Frodl, T., Carballedo, A., Hughes, M.M., Saleh, K., Fagan, A., Skokauskas, N., McLoughlin, D.M., Meaney, J., O'Keane, V., Connor, T.J., 2012. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl. Psychiatry 2, e88.
26. Fuller-Thomson, E., Nimigon-Young, J., Brennenstuhl, S., 2012. Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey. Rheumatol. Int. 32, 853-862.
27. Gold, P.W., Chrousos, G.P., 2002. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7, 254-275.
28. Gonda, X., Juhasz, G., Laszik, A., Rihmer, Z., Bagdy, G., 2005. Subthreshold depression is linked to the functional polymorphism of the 5HT transporter gene. J. Affect. Disord. 87, 291-297.
29. Gormley, G.J., Lowy, M.T., Reder, A.T., Hospelhorn, V.D., Antel, J.P., Meltzer, H.Y., 1985. Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am. J. Psychiatry 142, 1278-1284.
30. Hamdi, H., Godot, V., Maillot, M.C., Prejean, M.V., Cohen, N., Krzysiek, R., Lemoine, F.M., Zou, W., Emilie, D., 2007. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 110, 211-219.
31. Hanke, M.L., 2010. Sympathetic Nervous System Mediated Alterations in the Immunological and Behavioral Effects of Social Defeat. In Integrated Biomedical Science Graduate Program. The Ohio State University160.
32. Henckens, M.J.A.G., Pu, Z., Hermans, E.J., van Wingen, G.A., Joëls, M., Fernández, G., 2012. Dynamically changing effects of corticosteroids on human hippocampal and prefrontal processing. Hum. Brain Mapp. 33, 2885-2897.
33. Herman, J.P., Ulrich-Lai, Y.M., 2009. Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 10 (397+).
34. Heuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.H., Nemeroff, C.B., Holsboer, F., 1998. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress. Anxiety 8, 71-79.
35. Holsboer, F., Lauer, C.J., Schreiber, W., Krieg, J.C., 1995. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62, 340-347.
36. Holsboer, F., 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
37. Hu, X., Li, W.P., Meng, C., Ivashkiv, L.B., 2003. Inhibition of IFN-gamma signaling by glucocorticoids. J. Immunol. (Baltimore, Md.: 1950) 170, 4833-4839.
38. Juruena, 2010. The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment. Psychoneuroendocrinology 35, 1486-1491.
39. Kato, K., Sullivan, P.F., Evengård, B., Pedersen, N.L., 2009. A population-based twin study of functional somatic syndromes. Psychol. Med. 39, 497-505.
40. Kellendonk, C., Gass, P., Kretz, O., Schütz, G., Tronche, F., 2002. Corticosteroid receptors in the brain: gene targeting studies. Brain Res. Bull. 57, 73-83.
41. Klok, M.D., Alt, S.R., Irurzun Lafitte, A.J.M., Turner, J.D., Lakke, E.A.J.F., Huitinga, I., Muller, C.P., Zitman, F.G., Ronald de Kloet, E., DeRijk, R.H., 2011. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J. Psychiatr. Res. 45, 871-878.
42. Kumar, R., Thompson, E.B., 2005. Gene regulation by the glucocorticoid receptor: structure: function relationship. J. Steroid Biochem. Mol. Biol 94, 383-394.
43. Liu, Y., Ho, R., Mak, A., 2012. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord 139, 230-239.
44. Lupien, 1998. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1, 69-73.
45. Macedo, J.A., Hesse, J., Turner, J.D., Meyer, J., Hellhammer, D.H., Muller, C.P., 2008. Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology 33, 799-809.
46. Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., Neels, H., 1997. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853-858.
47. McBeth, J., Chiu, Y.H., Silman, A.J., Ray, D., Morriss, R., Dickens, C., Gupta, A., Macfarlane, G.J., 2005. Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res. Ther 7.
48. McGowan, 2009. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342-348.
49. Mineka, S., Watson, D., Clark, L.A., 1998. Comorbidity of anxiety and unipolar mood disorders. Annu. Rev. Psychol 49, 377-412.
50. Modell, S., Lauer, C.J., Schreiber, W., Huber, J., Krieg, J.C., Holsboer, F., 1998. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18, 253-262.
51. Oitzl, M.S., Fluttert, M., Sutanto, W., De Kloet, E.R., 1998. Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur. J. Neurosci 10, 3759-3766.
52. Ordway, G.A., Stockmeier, C.A., Cason, G.W., Klimek, V., 1997. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J. Neurosci. the official journal of the Society for Neuroscience 17, 1710-1719.
53. Pariante, C.M., Miller, A.H., 2001. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49, 391-404.
54. Pariante, C.M., 2003. Depression, stress and the adrenal axis. J. Neuroendocrinol 15, 811-812.
55. Patel, P.D., Lopez, J.F., Lyons, D.M., Burke, S., Wallace, M., Schatzberg, A.F., 2000. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J. Psychiatr. Res. 34, 383-392.
56. Peiffer, A., Veilleux, S., Barden, N., 1991. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 16, 505-515.
57. Przegalinski, 1993. The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats. Neuropharmacology 32, 1397-1400.
58. Quax, R.A., Koper, J.W., de Jong, P.H., van Heerebeek, R., Weel, A.E., Huisman, A.M., van Zeben, D., de Jong, F.H., Lamberts, S.W., Hazes, J.M., Feelders, R.A., 2012. In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis. Arthritis Res. Ther. 14, R195.
59. Raadsheer, F.C., Hoogendijk, W.J., Stam, F.C., Tilders, F.J., Swaab, D.F., 1994. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60, 436-444.
60. Reichardt, H.M., Kaestner, K.H., Wessely, O., Gass, P., Schmid, W., Schütz, G., 1998. Analysis of glucocorticoid signalling by gene targeting. J. Steroid Biochem. Mol. Biol 65, 111-115.
61. Reul, J.M., Gesing, A., Droste, S., Stec, I.S., Weber, A., Bachmann, C., Bilang Bleuel, A., Holsboer, F., Linthorst, A.C., 2000. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur. J. Pharmacol 405, 235-249.
62. Ridder, S., Chourbaji, S., Hellweg, R., Urani, A., Zacher, C., Schmid, W., Zink, M., Hortnagl, H., Flor, H., Henn, F.A., Schutz, G., Gass, P., 2005. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 25, 6243-6250.
63. Ruzek, M.C., Miller, A.H., Opal, S.M., Pearce, B.D., Biron, C.A., 1997. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med 185, 1185-1192.
64. Seckl, J.R., Dickson, K.L., Yates, C., Fink, G., 1991. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 561, 332-337.
65. Seckl, J.R., Fink, G., 1992. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 55, 621-626.
66. Selye, H., 1950. Stress and the general adaptation syndrome. Br. Med. J. 1, 1383-1392.
67. Sigalas, P.D., Garg, H., Watson, S., McAllister-Williams, R.H., Ferrier, I.N., 2012. Metyrapone in treatment-resistant depression. Ther. Adv. Psychopharmacol 2, 139-149.
68. Soundararajan, R., Wang, J., Melters, D., Pearce, D., 2007. Differential activities of glucocorticoid-induced leucine zipper protein isoforms. J. Biol. Chem. 282, 36303-36313.
69. Srinivasan, M., Janardhanam, S., 2011. Novel p65 binding glucocorticoid-induced leucine zipper peptide suppresses experimental autoimmune encephalomyelitis. J. Biol. Chem. 286, 44799-44810.
70. Staner, L., 2003. Sleep and anxiety disorders. Dialogues Clin. Neurosci 5, 249-258.
71. Starkman, M.N., 2013. Neuropsychiatric findings in cushing syndrome and exogenous glucocorticoid administration. Endocrinol. Metab. Clin. North Am. 42, 477-488.
72. Stetler, C., Miller, G., 2011. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73, 114-126.
73. Tsigos, C., Chrousos, G.P., 2002. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res 53, 865-871.
74. van den Heuvel, M.M., van Beek, N.M., Broug Holub, E., Postmus, P.E., Hoefsmit, E.C., Beelen, R.H., Kraal, G., 1999. Glucocorticoids modulate the development of dendritic cells from blood precursors. Clin. Exp. Immunol 115, 577-583.
75. van der Laan, S., Sarabdjitsingh, R.A., Van Batenburg, M.F., Lachize, S. B., Li, H., Dijkmans, T.F., Vreugdenhil, E., de Kloet, E.R., Meijer, O. C., 2008. Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain. J Neurochem. 106, 2515-2523.
76. van Rossum, E.F.C., Binder, E., Majer, M., Koper, J., Ising, M., Modell, S., Salyakina, D., Lamberts, S.W.J., Holsboer, F., 2006. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol. Psychiatry 59, 681-688.
77. van Zuiden, M., Geuze, E., Maas, M., Vermetten, E., Heijnen, C.J., Kavelaars, A., 2009. Deployment-related severe fatigue with depressive symptoms is associated with increased glucocorticoid binding to peripheral blood mononuclear cells. Brain Behav. Immun 23, 1132-1139.
78. van Zuiden, M., Geuze, E., Willemen, H.L., Vermetten, E., Maas, M., Amarouchi, K., Kavelaars, A., Heijnen, C.J., 2012. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol. Psychiatry 71, 309-316.
79. Wayne, C.D., Joseph, L.P., Joseph, R.S., Richard, D.T., Theodore, R., Michael, V., Marcus, E.R., 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827.
80. Webster, M.J., Knable, M.B., O'Grady, J., Orthmann, J., Weickert, C.S., 2002. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry 7 (985-94), 924.
81. Weindenfeld, J., Newman, M.E., Itzik, A., Gur, E., Feldman, S., 2002. The amygdala regulates the pituitary-adrenocortical response and release of hypothalamic serotonin following electrical stimulation of the dorsal raphe nucleus in. Neuroendocrinology 76, 63-69.
82. Wohleb, E.S., Hanke, M.L., Corona, A.W., Powell, N.D., Stiner, L.T.M., Bailey, M.T., Nelson, R.J., Godbout, J.P., Sheridan, J.F., 2011. β-adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 6277-6288.
83. World Health Organisation, 2008. The Global Burden of Disease: 2004 Update. Vol., (Ed.), Geneva, Switzerland, pp. 51.
84. Yang, K., Xie, G., Zhang, Z., Wang, C., Li, W., Zhou, W., Tang, Y., 2007. Levels of serum interleukin (IL)-6, IL-1β, tumour necrosis factor-α and leptin and their correlation in depression. Aust. N. Z. J. Psychiatry. 41, 266-273.
85. Yehuda, R., Boisoneau, D., Mason, J.W., Giller, E.L., 1993. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol. Psychiatry 34, 18-25.
86. Zhang, X.H., Lu, X., Long, X.B., You, X.J., Gao, Q.X., Cui, Y.H., Liu, Z., 2009. Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper. Clin. Exp. Allergy 39, 647-654.
87. Zobel, 1999. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am. J. Psychiatry 156, 949-951.